Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin vs HCQ/Darunavir/Ritonavir for Asymptomatic COVID-19
NCT04435587Phase 4Unknown
- Sponsor
- Mahidol University
- Start
- Jul 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of CHILD-IVITAB in coronavirus disease 2019 (COVID-19), sponsored by Mahidol University. Status: unknown.
02
Drugs
CHILD-IVITAB
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04435587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04435587.